| Study ID | Study Title | Language |
Clinical Study Result
|
Plain Language Summary
|
| 1941-CL-0004 | A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects with Type 2 Diabetes Mellitus |
|
English
|
English
|
| 1941-CL-0005 | Phase 2b, Double-Blind, Randomized, Multicenter, Parallel Group, Placebo-Controlled, Dose-Finding Study to Evaluate the Efficacy, Safety and Tolerability of a 12-Week Treatment with ASP1941 in Combination with Metformin in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Alone |
|
English
|
English
|
| 1941-CL-0016 | A Phase 2a, Randomized, Double-Blind, Placebo Controlled, Multiple Dose Study to Assess the Safety and Tolerability of ASP1941 in Adult Patients with Type 2 Diabetes Mellitus |
|
English
|
English
|
| 1941-CL-0050 | An exploratory study to investigate the effects of ipragliflozin (ASP1941) on glucose homeostasis and urinary glucose excretion in healthy subjects and subjects with type 2 diabetes mellitus (T2DM) |
|
English
|
English
|